Who
Tiago Marques
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Pasithea Therapeutics.
In numbers
- Trades disclosed
- 21
- Buys
- 1
- Sells
- 1
- Bought
- $25K
- Sold
- $797
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Dec 2021
- Last trade
- 1 May 2026
- Last filed
- 5 May 2026
Companies traded
Activity over time
1 May 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 May 2026filed 5 May 2026 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,756,069 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,756,069 at $0.00 | filing |
| 28 Nov 2025filed 1 Dec 2025 | KTTA Pasithea TherapeuticsBiotechnology | SEC FORM 4 Bought | $25K33,333 at $0.75 | filing |
| 24 Oct 2025filed 27 Oct 2025 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —493,341 at $0.00 | filing |
| 12 May 2025filed 14 May 2025 | KTTA Pasithea TherapeuticsBiotechnology | SEC FORM 4 Sold | $797960 at $0.83 | filing |
| 1 Mar 2024filed 5 Apr 2024 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 1 Mar 2024filed 5 Apr 2024 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,669 at $0.00 | filing |
| 1 Mar 2024filed 1 Mar 2024 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 1 Mar 2024filed 1 Mar 2024 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,669 at $0.00 | filing |
| 25 Nov 2022filed 28 Nov 2022 | KTTA Pasithea TherapeuticsBiotechnology | SEC FORM 4 Code A | $2,0602,000 at $1.03 | filing |
| 23 Nov 2022filed 28 Nov 2022 | KTTA Pasithea TherapeuticsBiotechnology | SEC FORM 4 Code A | $5,0005,000 at $1.00 | filing |
| 23 Nov 2022filed 28 Nov 2022 | KTTA Pasithea TherapeuticsBiotechnology | SEC FORM 4 Code A | $1,0301,000 at $1.03 | filing |
| 23 Nov 2022filed 28 Nov 2022 | KTTA Pasithea TherapeuticsBiotechnology | SEC FORM 4 Code A | $1,2301,206 at $1.02 | filing |
| 21 Oct 2022filed 21 Oct 2022 | KTTA Pasithea TherapeuticsBiotechnology | SEC FORM 4 Code A | $648600 at $1.08 | filing |
| 21 Oct 2022filed 21 Oct 2022 | KTTA Pasithea TherapeuticsBiotechnology | SEC FORM 4 Code A | $4,7084,400 at $1.07 | filing |
| 23 Jun 2022filed 23 Jun 2022 | KTTA Pasithea TherapeuticsBiotechnology | SEC FORM 4 Code A | $2,8712,900 at $0.99 | filing |
| 23 Jun 2022filed 23 Jun 2022 | KTTA Pasithea TherapeuticsBiotechnology | SEC FORM 4 Code A | $196200 at $0.98 | filing |
| 23 Jun 2022filed 23 Jun 2022 | KTTA Pasithea TherapeuticsBiotechnology | SEC FORM 4 Code A | $99100 at $0.99 | filing |
| 23 Jun 2022filed 23 Jun 2022 | KTTA Pasithea TherapeuticsBiotechnology | SEC FORM 4 Code A | $1,7821,800 at $0.99 | filing |
| 20 Dec 2021filed 22 Dec 2021 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.